Steminent Biotherapeutics (ROCO:7729) ROE % Adjusted to Book Value : -9.82% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Steminent Biotherapeutics ROE % Adjusted to Book Value?

Steminent Biotherapeutics's ROE % for the quarter that ended in Jun. 2024 was -36.54%. Steminent Biotherapeutics's PB Ratio for the quarter that ended in Jun. 2024 was 3.72. Steminent Biotherapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -9.82%.

Steminent Biotherapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Steminent Biotherapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Steminent Biotherapeutics ROE % Adjusted to Book Value Chart

Steminent Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Steminent Biotherapeutics Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-	-	-9.82

Competitive Comparison of Steminent Biotherapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Steminent Biotherapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Steminent Biotherapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Steminent Biotherapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Steminent Biotherapeutics's ROE % Adjusted to Book Value falls into.

Steminent Biotherapeutics ROE % Adjusted to Book Value Calculation

Steminent Biotherapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-39.37%	/	N/A
	=	N/A

Steminent Biotherapeutics's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-36.54%	/	3.72
	=	-9.82%

Steminent Biotherapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Steminent Biotherapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Steminent Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Steminent Biotherapeutics Inc (ROCO:7729) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445

Website

http://www.steminent.com

Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.

Steminent Biotherapeutics Headlines

No Headlines